Cardiovascular

02 – Cardiovascular

Wiltshire BSW STP Antiplatelets Summary (GWH & RUH pts only)
INR Self Testing Guidance
BSW Sacubitril Valsartan for Heart Failure
Wiltshire Omega-3 - advisory summary
How should conversion between doxazosin formulations be carried out in patients with hypertension
Wiltshire Diltiazem Dosing Regimes
Wiltshire Compression and Lymphoedema Garments
NICE Hypertension Guidance
NICE Hypertension Guidance – Patient Decision Aid

Direct Oral Anticoagulants (DOACs – formerly NOACs)

BSW Guidance on converting between anticoagulants
BSW PrescQIPP Atrial fibrillation: Patient information and decision aid
BSW PrescQIPP Prescriber decision support - Warfarin
BSW PrescQIPP Patient information - Non-vitamin K antagonist oral anticoagulants (NOACs)
BSW PrescQIPP Comparison of novel oral anticoagulants (NOACs)
BSW PrescQIPP Drug interactions with NOACs
BSW PrescQIPP Considerations for anticoagulationin Venous Thrombo-embolism (VTE)
BSW Direct Oral Anticoagulants (DOACs) for DVT and PE in adults: Local pathways
BSW PrescQIPP Anticoagulation Bulletin
BSW PrescQIPP Anticoagulation Briefing

Statins

Wiltshire Management of Lipids in Primary Care